Insuman Comb 15 Solostar (Insulin Human)

Insulin human mimics the action of natural insulin by binding to insulin receptors on muscle, fat and liver cells. This binding activates intracellular pathways that move glucose transporters to the cell surface, increase glucose uptake, suppress hepatic glucose production, and promote storage of glucose as glycogen, thereby lowering blood sugar.

The dose is individualized by the prescribing healthcare professional based on factors such as the patient’s blood glucose readings, body weight, diet, activity level, renal function and concurrent medications. Regular monitoring and dose titration are essential to achieve optimal glycemic control while minimizing hypoglycemia.

Insulin is generally considered the treatment of choice for diabetes in pregnancy because it does not cross the placenta in significant amounts. However, use of Insuman Comb 15 Solostar should be guided by a qualified obstetric or endocrine specialist who will weigh the benefits against any potential risks to the mother and fetus. Breastfeeding mothers should also consult their provider.

To place an enquiry, visit the product page on gnhindia.com, enter the required quantity and submit the request. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics) and any necessary import documentation.

Insuman Comb 15 Solostar contains human insulin, which has a shorter onset and duration than many long‑acting insulin analogues (e.g., glargine, detemir). It offers both basal and prandial coverage in a single formulation, making it useful for flexible dosing. Compared with rapid‑acting analogues, its action profile is slightly slower, which may influence timing of meals and injection schedules.

The product must be stored refrigerated at 2 °C to 8 °C. It should be kept in its original carton, protected from light, and must not be frozen or shaken. Once in use, the vial can be kept at room temperature for up to 28 days, but any unused solution should be discarded after that period.

Insuman Comb 15 Solostar is administered by subcutaneous injection, typically into the abdomen, thigh or upper arm. The injection site should be rotated to reduce the risk of lipodystrophy. Patients should follow the prescriber’s instructions regarding dose, timing relative to meals, and proper injection technique.

The most serious risks include severe hypoglycemia, which can lead to loss of consciousness or seizures, and anaphylactic reactions that may be life‑threatening. Rarely, patients may develop insulin antibodies that alter drug efficacy. Prompt recognition of symptoms and immediate medical attention are essential.

Individuals with a known hypersensitivity to human insulin or any excipients in the formulation should avoid this product. It is also contraindicated in patients experiencing hypoglycemia until the condition is corrected. Patients with severe renal or hepatic impairment should use it only under close medical supervision.